23.03
前日終値:
$23.51
開ける:
$23.66
24時間の取引高:
753.08K
Relative Volume:
0.77
時価総額:
$1.80B
収益:
$399.58M
当期純損益:
$-54.04M
株価収益率:
-30.71
EPS:
-0.75
ネットキャッシュフロー:
$40.13M
1週間 パフォーマンス:
-13.58%
1か月 パフォーマンス:
-12.73%
6か月 パフォーマンス:
-47.18%
1年 パフォーマンス:
-0.65%
Veracyte Inc Stock (VCYT) Company Profile
名前
Veracyte Inc
セクター
電話
(650) 243-6300
住所
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
VCYT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
VCYT
Veracyte Inc
|
23.03 | 2.09B | 399.58M | -54.04M | 40.13M | -0.75 |
![]()
TMO
Thermo Fisher Scientific Inc
|
404.94 | 160.56B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
188.07 | 141.52B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
520.87 | 42.74B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
112.04 | 34.11B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
158.96 | 27.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-03-20 | 開始されました | Craig Hallum | Buy |
2024-12-05 | ダウングレード | Goldman | Buy → Neutral |
2024-11-15 | 開始されました | Wolfe Research | Outperform |
2024-10-16 | 開始されました | UBS | Buy |
2024-10-10 | 開始されました | Guggenheim | Buy |
2024-02-23 | 繰り返されました | Needham | Buy |
2023-01-18 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
2022-01-07 | 開始されました | Stephens | Overweight |
2021-11-18 | 再開されました | Goldman | Buy |
2021-06-15 | 開始されました | Raymond James | Outperform |
2021-02-18 | 再開されました | Needham | Buy |
2021-01-28 | 開始されました | Truist | Buy |
2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
2020-09-09 | 開始されました | Morgan Stanley | Underweight |
2019-07-31 | 開始されました | Lake Street | Buy |
2019-07-02 | 開始されました | Needham | Buy |
2018-11-29 | ダウングレード | Janney | Buy → Neutral |
2018-10-31 | アップグレード | Janney | Neutral → Buy |
2017-11-07 | ダウングレード | Janney | Buy → Neutral |
2017-11-07 | ダウングレード | Piper Jaffray | Overweight → Neutral |
2017-08-31 | 再開されました | BTIG Research | Buy |
2016-11-14 | 再開されました | Leerink Partners | Outperform |
2015-12-18 | 開始されました | Cantor Fitzgerald | Buy |
2015-06-11 | 繰り返されました | Leerink Partners | Outperform |
2013-11-26 | 開始されました | William Blair | Outperform |
すべてを表示
Veracyte Inc (VCYT) 最新ニュース
What analysts say about Veracyte Inc. stockUnrivaled growth potential - jammulinksnews.com
What drives Veracyte Inc. stock priceExceptional stock performance - Autocar Professional
Are Veracyte, Inc.'s (NASDAQ:VCYT) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - simplywall.st
Is Veracyte Inc. a good long term investmentHigh-margin investment plays - Autocar Professional
Veracyte Inc. Stock Analysis and ForecastFree Daily Trading Room Entry - jammulinksnews.com
Principal Financial Group Inc. Raises Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
When is the best time to buy Veracyte Inc. stockMinimized Risk Maximum Return - Newser
Will Veracyte Inc. stock split in the near futureBreakout Momentum Stocks - Newser
Veracyte, Inc. (NASDAQ:VCYT) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Veracyte to Release Second Quarter 2025 Financial Results on August 6, 2025 - Lelezard
Should You Continue to Hold Veracyte Stock in Your Portfolio Now? - Nasdaq
How Veracyte Inc. stock performs during market volatility5x Profit Potential - Newser
Why Veracyte Inc. stock attracts strong analyst attentionReal Chart Play - Newser
What makes Veracyte Inc. stock price move sharplyTop Performer Shortlist - Newser
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Teacher Retirement System of Texas - Defense World
Allspring Global Investments Holdings LLC Purchases 4,792 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Veracyte Announces that Multiple Afirma GRID Studies Will Be Presented at ENDO 2025 - BioSpace
Veracyte's Afirma GRID Studies at ENDO 2025: A Paradigm Shift in Thyroid Cancer Diagnostics and Personalized Medicine - AInvest
Veracyte, Inc. Announces Multiple Afirma Grid Studies Will Be Presented At Endo 2025 - MarketScreener
Veracyte's Afirma GRID: Pioneering Precision Oncology and Driving Sustainable Growth - AInvest
Wealth Enhancement Advisory Services LLC Grows Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Veracyte Q3 2024 slides: Revenue surges 29%, guidance raised for third time By Investing.com - Investing.com South Africa
Veracyte Q3 2024 slides: Revenue surges 29%, guidance raised for third time - Investing.com Canada
Veracyte's Russell 2000 Growth Index Inclusion: A Catalyst for Liquidity and Institutional Momentum - AInvest
Veracyte: A Hidden Gem in Precision Diagnostics Amid Index Exclusion - AInvest
Wall Street Zen Downgrades Veracyte (NASDAQ:VCYT) to Hold - Defense World
Veracyte exploring external buyers for divestiture of French unit’s activities - TipRanks
GAMMA Investing LLC Purchases 18,840 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Veracyte shareholders approve 2.5 million share increase to equity plan - Investing.com
Veracyte shareholders approve 2.5 million share increase to equity plan By Investing.com - Investing.com India
Insider Sell: Karin Eastham Sells Shares of Veracyte Inc (VCYT) - GuruFocus
Recent 3.7% Pullback Isn't Enough to Hurt Long-term Veracyte (NASDAQ:VCYT) Shareholders, They're Still up 56% Over 3 Years - 富途牛牛
Veracyte, Inc.'s (NASDAQ:VCYT) Shares Lagging The Industry But So Is The Business - simplywall.st
Veracyte (VCYT) Fell Despite Reporting Revenue Growth and Improved Profitability - Insider Monkey
Veracyte Inc (VCYT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):